Aim: Increased clusterin mRNA and protein levels have been detected in various tissues undergoing stress, and we previously reported that clusterin is markedly induced in media and neointima following vascular injury. The present study therefore investigated the impact of clusterin on neointimal hyperplasia following vascular injury. 
lem. Identifying the molecules involved in restenosis after PCI will help to develop new strategies for the prevention of restenosis. Neointimal hyperplasia is a major cause of restenosis after PCI 5) . We previously reported that clusterin was markedly induced in media and neointima following vascular injury, and the expression of clusterin stimulated the proliferation and migration of cultured vascular smooth muscle cells (VSMCs) in vitro 6) . Moreover, clusterin antisense was reported to inhibit the proliferation of cultured VSMC obtained from neointima after ballooning in vitro 7)
Introduction
Percutaneous coronary intervention (PCI) is a useful procedure for the treatment of coronary stenosis. Sirolimus-eluting and polymeric paclitaxel-eluting stents strongly suppress neointimal hyperplasia [1] [2] [3] ; however, meta-analysis of randomized clinical trials of drug-eluting stents reported that the rate of angiographic restenosis after drug-eluting stents is 8.9% 4) . Thus, restenosis after PCI is still a significant prob-linked glycoprotein (449 amino acids) that is expressed in virtually all tissues and is found in most physiological fluids, including human plasma, urine, breast milk, semen, and cerebrospinal fluid 8, 9) . The wide distribution and sequence conservation of clusterin suggests that this protein performs functions of fundamental biological importance. It is involved in numerous physiological processes important for carcinogenesis and tumor growth, including apoptotic cell death, cell-cycle regulation, DNA repair, cell adhesion, tissue remodeling, lipid transportation, membrane recycling, and immune system regulation. Increased clusterin mRNA and protein levels have been consistently detected in various tissues after stress, including the heart, brain, liver, kidney, breast, and retinal tissues both in vivo and in vitro 10) . The purpose of this study was to investigate the impact of clusterin on neointimal hyperplasia following vascular injury in vivo, and to clarify the precise mechanism of the effect of clusterin on the proliferation of VSMC in vitro.
Materials and Methods

Mice
This study was performed under the supervision of the Animal Research Committee in accordance with the guidelines on animal experiments of the Faculty of Medicine, Kagoshima University. We used C57BL6 (wild-type) and clusterin knockout mice (clusterin-KO) in this study. Clusterin-KO mice were as described by McLaughlin et al.
11)
. We used 8-weekold male mice that weighed 24 − 30 g. The animals were given a standard diet and water ad libitum. In order to confirm the deficiency of clusterin, mice tails were biopsied at 8 weeks of age. Genomic DNA was isolated using proteinase K and analyzed with the polymerase chain reaction as described.
Cuff Placement
Neointimal formation in the femoral artery of mice was induced by placement of a polyethylene cuff as described previously 12, 13) . Mice were anesthetized with pentobarbital (50 mg/kg) by intraperitoneal injection and diethyl ether. The right femoral artery of the mouse was exposed and isolated from the surrounding tissues. A non-constrictive polyethylene cuff (length, 2.0 mm; inner diameter, 0.40 mm; outer diameter, 0.80 mm; Natsume, Tokyo, Japan) was cut longitudinally and loosely placed around the right femoral artery and tied in place with an 8-0 silk suture. The cuff was larger than the vessel and did not obstruct blood flow. The left femoral artery was dissected from the surrounding tissue, but a cuff was not placed (sham-operated). The wounds were closed with sutures.
Tissue Harvesting and Lipid Analysis
Four weeks after cuff placement, the mice were killed by an overdose of pentobarbital. For morphometric analysis, the thorax was opened, and blood samples were taken through a 23-gauge butterfly angiocatheter placed in the left ventricle. Subsequently, the mice were perfused with PBS, and the vessels were perfusion-fixed at 100 mmHg with 10% neutral-buffered formalin. The cuffed artery and sham-operated artery were harvested and then postfixed in 10% neutral-buffered formalin overnight and embedded in paraffin.
The concentration of plasma total cholesterol and high density lipoprotein (HDL) cholesterol was measured enzymatically using a commercially available kit (Kainos Laboratories, Tokyo, Japan).
Morphometric Analysis
The artery was cut into three subserial cross sections of 10 m thickness at intervals of 0.5 mm. The sections were stained by hematoxylin and eosin (H&E) and Elastica van Gieson, and photographed with a microscale. The areas of the media and neointima were measured using image analyzing software (NIH image) by an observer blinded to the animal's genotype. Neointima was defined as the area between the vessel lumen and the internal elastic lamina. Media was defined as the area between the internal elastic lamina and the external elastic lamina. We also calculated the intima-to-media ratio (I/M ratio) of each section. The average value of these sections was taken as the value for each animal.
Immunohistochemistry
Immunohistochemical staining of the tissue sections was performed as described previously 6) by the labeled streptavidin-biotin complex method (Nichirei Bioscience, Tokyo, Japan). A goat polyclonal antibody against human apoJ (Rockland Immunochemicals, Gilbertsville, PA), a goat polyclonal antibody against human p53 (Santa Cruz Biotechnology, Santa Cruz, CA), a rabbit polyclonal antibody against human activated caspase-3 (BD Bioscience, Franklin Lakes, NJ), and a rabbit polyclonal antibody against human p21 (Santa Cruz Biotechnology) were used as primary antibodies. The specificity of the immunoreaction was evaluated in comparison with a negative control specimen in which goat or rabbit IgG was used instead of the primary antibody.
VSMC Isolation from Clusterin-KO and Wild-Type Mice
VSMCs were isolated by an explant method from the medial layer of the thoracic aorta obtained from clusterin-KO or wild-type mice. VSMCs were cultured in DMEM containing 5% FBS in a humidified atmosphere and 5% CO2 − 95% air as described previously 14) . VSMCs from the fifth to tenth passage were used in the experiments. The identity of cultured VSMC was confirmed by microscopic identification of their characteristic "hill-and-valley" growth pattern and by immunohistochemical identification of smooth muscle actin using a specific monoclonal antibody (human -actin; Santa Cruz Biotechnology).
Static Stretch System
The strain unit, Flexcell FX-2000 (Flexcell International, Hillsborough, NC), consists of a vacuum unit linked to a valve controlled by a computer program. VSMCs cultured on the flexible membrane base were subjected to static stretch produced by this computer-controlled application of sinusoidal negative pressure as described previously 15, 16) . Flex I culture plates not subjected to static stretch served as controls.
Proliferation Assay of VSMC with or without Stretch
VSMCs from wild-type or clusterin-KO mice were cultured on Flex I 6-well plates coated with typecollagen (density, 2 10 5 /well) with medium containing 5% FBS. After 48 h, VSMCs were exposed to static stretch provided by 25% radial stretch of the membrane for 10 min. After 48 h with or without stretch, we demonstrated VSMC proliferation by counting cells with an electronic counter (Sysmex, Hyogo, Japan).
In addition, after 24 h with or without stretch, we used VSMCs for Western blotting and cell-cycle analysis by flow cytometry.
Western Blotting
For Western blotting of clusterin, p53, p21, cleaved caspase-3, and -actin, proteins were extracted from cultured VSMCs of clusterin-KO mice, wildtype mice, and rat aorta as reported previously 17, 18) . Cells were incubated in ice-cold 0.1% Triton lysis solution [mmol/L: HEPES 10 (pH 7.4), sodium pyrophosphate 50, NaF 50, EDTA 5, EGTA 5, and NaCl 50, and 100 mmol/L Na3VO4, 0.1% Triton X-100, 500 mmol/L PMSF, and 10 mg/mL leupeptin] for 1 h.
Insoluble matter was removed by centrifugation, and the protein concentration was measured by a bicinchoninic acid assay (PIERCE Biotechnology, Rockford, IL). Western blotting was performed with a NuPAGE Electrophoresis System (Invitrogen, Carlsbad, CA) as reported previously 19) . Briefly, protein samples were resuspended in reduced sample buffer, electrophoresed on a 4 − 12% Bis-Tris gel (Invitrogen) with MOPS running buffer, blotted to a PVDF membrane (Millipore, Billerica, MA), and sequentially probed with a goat polyclonal antibody against mouse clusterin, a mouse monoclonal antibody against human p53, a rabbit polyclonal antibody against human p21, a rabbit polyclonal antibody against human cleaved caspase-3, and a mouse monoclonal antibody against human -actin (all from Santa Cruz Biotechnology). Either horseradish peroxidase-conjugated goat antimouse antibody, goat anti-rabbit antibody, or donkey anti-goat antibody (all from Santa Cruz Biotechnology) was then added, and the secondary antibody was detected by autoradiography using enhanced chemiluminescence (GE Healthcare, Little Chalfont, England). The expression of -actin was used as a reference for quantification of the respective proteins. Densitometric analysis was performed to quantitate the protein expression of clusterin, p53, p21, and -actin using NIH image software. The -actin protein was used as a reference for quantitation of clusterin, p53, and p21.
Flow Cytometry for Cell Cycle Analysis
The cell cycle was assessed by flow cytometry (Beckmann Coulter, Fullerton, CA). VSMCs were fixed with 70% ethanol on ice for 30 min, washed with phosphate-buffered saline (PBS), treated with RNase A (100 g/mL) for 30 min at 37 and stained for DNA with propidium iodide (10 g/mL) for 15 min at room temperature. Cells were centrifuged, resuspended in 1 mL PBS, and analyzed using flow cytometry as described previously 20) .
Short-Interfering RNA Transfection and Stretch of Rat VSMCs
We used short-interfering (si) RNA to suppress the expression of clusterin. The sequences of siRNA against clusterin (clusterin-siRNA) were 5'-GGCUUUCCCGGAAGUGUGUdtdt-3' (sense) and 5'-ACACACUUCCGGGAAAGCCdtdt-3' (antisense). These siRNA and negative control siRNA (control-siRNA), a 21-nucleotide RNA duplex with no known sequence homology 21) , were purchased from Ambion (Austin, TX). For siRNA transfection, rat VSMCs were cultured on Flex I 6-well plates coated with type-collagen (density, 4 10 4 /well) with medium containing 10% FBS. After reaching 50 − 60% confluence, transfection of siRNA into rat VSMCs was achieved using oligofectamine (Invitrogen). Briefly, 20 mol/L stock siRNA and 8 L oligofectamine were diluted and mixed gently with 1 mL M199 to achieve the final concentration of oligofectamine, 8 L/well. Cultured cells were washed with M199 without serum and antibiotics. The oligonucleotide-oligofectamine complexes were then added to each well and the cells were incubated at 37 for 4 h. FBS was then added to the cells to achieve a final concentration of 5% in M199 and incubated for 2 h. The cells were then exposed to static stretch provided by 25% radial stretch of the membrane for 10 min. Twenty-four hours after stretching, total RNA was isolated from cultured VSMCs for reverse-transcription polymerase chain reaction (RT-PCR). Forty-eight hours after stretching, we analyzed the cell number and isolated protein for Western blotting as described previously 22) .
RT-PCR
RT-PCR was performed as described previously 17) . Total RNA for use in RT-PCR was isolated using the Mini RNA isolation kit (ZYMO RESEARCH, Orange, CA). For cDNA synthesis, 0.5 g total RNA was reverse-transcribed with random hexamers using SuperScript RT (Invitrogen). The transcribed cDNA was amplified by PCR with specific primers for clusterin and glyceraldehydes-3-phosphate dehydrogenase (GAPDH). Two specific primer pairs corresponding to published sequences were used to amplify clusterin (5'-TGATGGCCCTCTGGGAAGAGT-3' and 5'-TCTCCAGCAGGGAGTCGATGCG-3') 23) and GAPDH (5'-ATGGTGAAGGTCGGTGTG-3' and 5'-ACCAGTGGATGCAGGGAT-3') 24) . The PCR amplification protocol included 31 cycles of denaturing, annealing, and elongation with Taq polymerase (TaKaRa Bio, Shiga, Japan). Equal amounts of PCR products were subjected to electrophoresis through 2% agarose gels and visualized with ethidium bromide. GAPDH expression was used as a reference.
Statistical Analysis
All calculated data are presented as the mean S.D. and analyzed by unpaired Student's t test. A value of p 0.05 was considered significant.
Results
Mice
To clarify the impact of clusterin on vascular remodeling, we compared wild-type mice with clusterin-KO mice.
We measured the body weight and plasma level of total cholesterol and HDL cholesterol in wild-type and clusterin-KO mice at 12 weeks of age and found no significant difference (Fig. 1) .
Quantification of Intimal Lesions After Cuff Placement
We quantified morphometric changes in the injured artery of wild-type and clusterin-KO mice 4 weeks after cuff placement. There was no significant difference in the medial area between wild-type and clusterin-KO mice ( Fig. 2A, B) ; however, clusterin-KO mice demonstrated a significant decrease of the I/M ratio (p 0.01) as compared with wild-type mice (Fig. 2C) .
Analysis of Proliferation and Apoptosis of VSMCs in Intimal Lesions
In order to analyze the mechanism of the effect of clusterin deficiency on neointimal formation following vascular injury, we performed immunohistochemical staining using anti-p53 antibody. In clus- There was no significant difference in the body weight, plasma levels of total cholesterol and HDL cholesterol between wild-type and clusterin-KO.
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terin-KO mice, the accumulation of p53 in the nuclei of neointimal VSMCs was detected (Fig. 3) . This result suggested that apoptosis or G1 arrest occurred in neointimal VSMCs of clusterin-KO mice. Furthermore, we examined apoptosis using anti-activated caspase-3 antibody, and the immunoreactivity of activated caspase-3 in neointima demonstrated no differences between wild-type and clusterin-KO mice (Fig. 3) . We then performed immunohistochemistry on p21 to analyze G1 arrest of neointimal VSMCs. In clusterin-KO mice, p21 was accumulated in the nuclei of neointimal VSMCs (Fig. 3) , suggesting that G1 arrest occurred in neointimal VSMCs of clusterin-KO mice.
Proliferation Stimulated by Stretching in VSMCs Obtained from Clusterin-KO or Wild-Type Mice
VSMCs were explanted from the thoracic aorta obtained from clusterin-KO or wild-type mice. The cell number and protein expression of clusterin in wildtype VSMCs increased with the strength of stretch (Fig. 4) , and therefore, we decided to use the maximum 25% stretch for 10 min in this experiment. Fig. 5A demonstrates the fold increase of cell number after 48 h with or without 25% stretch for 10 min in wild-type and clusterin-KO VSMCs. Wild-type VSMCs showed a significant 1.2-fold increase of cell number by stretching, but clusterin-KO VSMCs did not. Immunohistochemical staining of clusterin, p53, activated caspase-3, and p21 in the injured femoral artery 4 weeks after cuff placement from wild-type and clusterin-KO mice. Arrows indicate internal elastic lamina. Representative sections of the injured femoral artery from wildtype and clusterin-KO mice 4 weeks after cuff placement, stained by H&E and Elastica Van Gieson (A). Arrows indicate internal elastic lamina. Quantification of the medial area (B) and the I/M ratio (C) of the injured femoral artery 4 weeks after cuff placement in wild-type (white bar) and clusterin-KO (black bar) (n 15 mice per group). There is no significant difference in the medial area between wild-type and clusterin-KO; however, clusterin-KO mice showed a significant decrease in the I/M ratio. All scale bars denote 25 m.
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Induction of p53 and p21 by Stretching in Clusterin-KO VSMCs Cultured VSMCs of clusterin-KO and wild-type mice were exposed to 25% static stretch for 10 min. After 24 h, the expressions of clusterin, p53, and p21 were analyzed by Western blot analysis. Clusterin was induced by 25% static stretch in wild-type VSMCs, but not in clusterin-KO VSMCs. In addition, the expression of p53 and p21 was induced by 25% static stretch in clusterin-KO VSMCs, but not in wild-type VSMCs (Fig. 5B) .
Cell Cycle Analysis
Next, cell cycle was analyzed by flow cytometry 24 h after 25% static stretch for 10 min. As shown in Fig. 5C , there was a significant progression to S and G2/M phases in clusterin-KO VSMCs compared with wild-type VSMCs 24 h after stretching, suggesting G1 arrest in clusterin-KO VSMCs (wild-type VSMCs: G0/G1 70.7 1.8%, S 6.4 1.8%, G2/M 21.8 1.7%, sub-G1 1.5 0.3% vs. clusterin-KO VSMCs: G0/G1 86.2 4.3%, S 3.9 1.0%, G2/M 8.2 3.0, sub-G1 1.3 0.7%).
Induction of Clusterin by Static Stretch and Knock Down by siRNA in Rat VSMCs
We analyzed the expression of clusterin in rat VSMCs transfected with control or clusterin-siRNA at 24 h after 25% stretch for 10 min. RT-PCR demonstrated that the expression of clusterin was upregulated by stretching in rat VSMCs. We confirmed that clusterin-siRNA but not control-siRNA inhibited the expression of clusterin mRNA induced by stretching (Fig. 6A) .
Clusterin-siRNA Decreased VSMC Proliferation Stimulated by Static Stretch
We analyzed the proliferation of rat VSMCs by counting cell numbers (Fig. 6B) . Static stretch of 25% for 10 min significantly increased the cell number compared with non-stretch (25% static stretch: 3.34 10 5 13,000 vs. non-stretch: 2.92 10 5 21,500, p 0.0001). At 48 h without stretch, there is no significant difference in the cell number of VSMCs transfected with control-siRNA and clusterin-siRNA (clusterin-siRNA: 2.72 10 5 15,500 vs. control-siRNA: 2.92 10 5 21,500). In contrast, at 48 h after stretching, the cell number of VSMCs treated with clusterinsiRNA was significantly lower than VSMCs treated with control-siRNA (clusterin-siRNA: 2.68 10 5 40,600 vs. control-siRNA: 3.34 10 5 13,000, p 0.001).
Clusterin-siRNA Upregulates p53 and p21 After Stretching
We analyzed the expressions of clusterin, p53 and p21 at 48 h after 25% static stretch for 10 min. Western blotting showed that treatment of rat VSMCs cultured with clusterin-siRNA decreased the expression of clusterin and upregulated the expression of p53 and p21 compared to VSMCs cultured with control-siRNA (Fig. 6C) .
Discussion
Clusterin has been implicated in various cell functions involved in carcinogenesis and tumor progression, including cell adhesion, tissue remodeling, 
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lipid transportation, membrane re-cycling, immune system and cell-cycle regulation, DNA repair, and apoptotic cell death 25) . In addition, clusterin was reported to function as an extracellular chaperone that stabilizes stressed proteins in a folding-competent state 8) . Increased clusterin mRNA and protein levels have been detected in various tissues undergoing stress, including heart, brain, liver, kidney, and retinal tissues both in vitro and in vivo.
Surprisingly, immunohistochemistry of the injured femoral artery in clusterin-KO mice demonstrated the accumulation of p53 in nuclei of neointimal VSMCs. Moreover, VSMCs from either clusterin-KO or rat VSMCs treated with siRNA that were subjected to static stretch exhibited significantly increased p53 and p21, and increased G1 cell cycle arrest as indicated by flow cytometry compared with wild-type VSMCs. Previous studies have reported that p53 acts as a transcriptional repressor of the clusterin gene 26, 27) ; however, we could not determine the precise molecular mechanism by which the inhibition of clusterin expression led to upregulation of p53. Both clusterin and p53 limit tissue injury and/or promote tissue remodeling; therefore, we speculate that p53 may be upregulated in order to compensate for the deficiency of clusterin in tissue damage or tissue The fold increase of cell number after 48 h with (black bar) or without (white bar) 25% stretch for 10 min in wild-type and clusterin-KO VSMCs (A) (n 6 per group). Western blotting (B) (n 3 replications) and cell cycle analysis by the flow cytometry (C) (n 4 times) at 24 h after 25% static stretch for 10 min in wild-type and clusterin-KO VSMCs. p 0.00001 versus wild-type G0/G1, p 0.05 versus wild-type S, p 0.00001 versus wild-type G2/M.
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remodeling.
The tumor suppressor p53 is a transcription factor which has been identified as a participant in the cellular DNA damage response resulting in either G1 arrest 28, 29) or apoptosis 28, 30, 31) . It is well established that the induction of p53 tumor suppressor protein can lead to either cell-cycle arrest or apoptosis. Several factors, including the cell type, the presence or absence of survival factors in the external environment, the extent of DNA damage, the level of p53 and posttranslational modifications, are involved in the choice between cell-cycle arrest and apoptosis 32) . In our experiments using clusterin-KO mice, vascular damage by cuff implantation upregulated p53, suggesting G1 arrest rather than apoptosis.
p53 is an important factor for maintaining genetic stability and is a cell-cycle check-point protein that helps to regulate progression from G1 into S phase. Many environmental insults and cancer treatments, including radiation and chemotherapeutic drugs, increase p53 levels, leading to a G1 phase cellcycle arrest [29] [30] [31] . The G1 arrest pathway involves p53- RT-PCR demonstrated the induction of clusterin by static stretch and knock down by clusterin-siRNA in rat VSMCs at 24 h after stretching for 10 min (A). 48 h after stretching, clusterin-siRNA decreased VSMC proliferation stimulated by 25% static stretch for 10 min (B) (n 6 per group). Western blotting showed that clusterin-siRNA decreased the expression of clusterin and upregulated the expressions of p53 and p21 in cultured rat VSMCs compared with control-siRNA at 48 h after 25% static stretch for 10 min (C) (n 3 replications).
dependent transcriptional activation of p21 28) . p21 inhibits G1 cyclin-Cdk complex, such as cyclin D-Cdk4/Cdk6 and cyclin E-Cdk2 33) . Inhibition of G1 cyclin-Cdk complex, in turn, inhibits phosphorylation of pRb 33, 34) , thereby preventing activation of E2F-responsive G1/S transition genes, such as dihydrofolate reductase and thymidylate synthase 35) . Thus, p53 helps to maintain genetic stability by preventing progression to the S phase under adverse conditions, such as those created by environmental stresses or treatment with anticancer agents 36) . In our in vitro experiments, we confirmed that clusterin-KO VSMCs subjected to stretching upregulated p53 and p21, and shifted to G1 arrest compared with wild-type VSMCs.
Clusterin expression has been associated with the progression of various human tumors, including bladder, colon, prostate, breast, lung, kidney, ovary, and lymphoma 25) . The elevated level of clusterin in human cancer may promote oncogenic transformation and tumor progression by interfering with Bax pro-apoptotic activity 37) . Silencing expression of the clusterin gene in human cancer cells using small interfering RNA was reported to induce spontaneous apoptosis, and reduce growth ability and cell sensitization to genotoxic and oxidative stress 9) . In the same way as gene therapy for cancer, silencing the expression of the clusterin gene in coronary arteries after PCI might be useful to prevent restenosis in the clinical setting.
In this study, the mechanism of cell injury is different between cuff placement (in vivo) and cell stretch (in vitro). Cuff placement induced neointimal formation following injury and inflammation of adventia of the femoral artery. Injury by both cuff placement and cell stretch upregulated the expression of clusterin in VSMCs.
As compared with wild-type mice, clusterin-KO mice demonstrated a significant decrease of neointimal hyperplasia following vascular injury. In addition, VSMCs from either clusterin-KO or rat VSMCs treated with siRNA that were subjected to static stretch exhibited significantly increased p53 and p21, and increased G1 cell-cycle arrest compared with wildtype VSMCs; therefore, clusterin represents a promising molecular target to limit restenosis after PCI. 
